Four cannabinoid derivatives are biosynthesized in engineered bacteria. Two mutants are engineered to selectively produce an undescribed compound with a C15 prenyl chain at the C-5 position and antineuroinflammatory and antibacterial activities.
- Qin Yan
- Yue-Gui Chen
- Sheng-Hong Li
